(EDIT) Editas Medicine complete technical analysis [charts+indicators] | Buy/Sell Editas Medicine | (EDIT) share price targets
Complete technical analysis of Editas Medicine (EDIT) by charts plus indicators, forecast predictions and share price targets for Editas Medicine (EDIT)
Editas Medicine trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-06 View latest technical analysis
10 day averaged volume of Editas Medicine is 2932880
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Thu Nov 2025 | 2.69 | 2.77 | 2.79 | 2.62 | 0.775 times |
| 05 Wed Nov 2025 | 2.78 | 2.83 | 2.88 | 2.71 | 0.427 times |
| 04 Tue Nov 2025 | 2.78 | 2.94 | 2.98 | 2.77 | 0.473 times |
| 31 Fri Oct 2025 | 3.08 | 3.01 | 3.37 | 2.95 | 2.175 times |
| 31 Fri Oct 2025 | 3.08 | 3.01 | 3.37 | 2.95 | 2.175 times |
| 30 Thu Oct 2025 | 3.01 | 3.00 | 3.07 | 2.94 | 0.404 times |
| 29 Wed Oct 2025 | 3.04 | 3.17 | 3.20 | 3.04 | 0.696 times |
| 28 Tue Oct 2025 | 3.17 | 3.26 | 3.29 | 3.11 | 0.671 times |
| 27 Mon Oct 2025 | 3.25 | 3.55 | 3.62 | 3.15 | 2.091 times |
| 24 Fri Oct 2025 | 3.72 | 3.75 | 3.87 | 3.71 | 0.507 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 3, but if it comes above 3, then a intra day buy could be more profitable.
If you take a sell trade below 3, then use 3 as stoploss and 2.5 as target. However if you take a buy trade in stock , then use 3 as stoploss and 3.42 as target.
Share price targets for Editas Medicine (EDIT)
| Target Type | Value |
| Downside Target | 2.07 |
| Downside Target | 2.39 |
| Downside Target | 2.62 |
| Upside Target | 2.94 |
| Upside Target | 3.17 |
| Upside Target | 3.32 |
| Upside Target | 3.48 |
| Upside Target | 3.58 |
| Upside Target | 3.62 |
| Upside Target | 4.28 |
| Upside Target | 4.33 |
| Upside Target | 4.54 |
Intraday share price targets for Editas Medicine (EDIT)
| Target Type | Value |
| Downside Intraday Target | 2.55 |
| Downside Intraday Target | 2.4 |
| Upside Intraday Target | 2.91 |
| Upside Intraday Target | 3.12 |
| Upside Intraday Target | 2.76 |
Weekly technical analysis of Editas Medicine (EDIT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Thu Nov 2025 | 2.69 | 2.94 | 2.98 | 2.62 | 0.77 times |
| 31 Fri Oct 2025 | 3.08 | 3.01 | 3.37 | 2.95 | 0.36 times |
| 31 Fri Oct 2025 | 3.08 | 3.55 | 3.62 | 2.94 | 1.49 times |
| 24 Fri Oct 2025 | 3.72 | 3.89 | 4.28 | 3.48 | 0.902 times |
| 17 Fri Oct 2025 | 3.70 | 3.84 | 4.33 | 3.32 | 0.751 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Editas Medicine (EDIT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Thu Nov 2025 | 2.69 | 2.94 | 2.98 | 2.62 | 0.063 times |
| 31 Fri Oct 2025 | 3.08 | 3.46 | 4.54 | 2.94 | 1.594 times |
| 30 Tue Sep 2025 | 3.47 | 2.52 | 3.62 | 2.39 | 1.375 times |
| 29 Fri Aug 2025 | 2.57 | 2.48 | 3.17 | 2.07 | 0.539 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Editas Medicine (EDIT)
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Editas Medicine stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Editas Medicine in short term and the sell signal is strong.
Editas Medicine Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Editas Medicine in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Editas Medicine is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.09 and Editas Medicine (EDIT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Editas Medicine (EDIT) stock. Volume based technical analysis of Editas Medicine (EDIT) stock is negative.
Editas Medicine Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Editas Medicine ( (EDIT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Editas Medicine stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Editas Medicine in short term and the sell signal is strong.
Editas Medicine Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Editas Medicine in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Editas Medicine is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.09 and Editas Medicine (EDIT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Editas Medicine (EDIT) stock. Volume based technical analysis of Editas Medicine (EDIT) stock is negative.
Editas Medicine Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.